Expression of survivin and VEGF-C in breast cancer tissue and its relation to lymphatic metastasis

European Journal of Gynaecological Oncology

Volumn 33, Issue 2, 2012, Pages 178-182

  Li, Xiangqi ^a   Dang, Xiangguo ^a   Sun, Xibo ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Lymphatic metastasis; Survivin; Vascular endothelial growth factor C

Indexed keywords

SURVIVIN; TUMOR MARKER; VASCULOTROPIN C;

ADULT; ARTICLE; BREAST CANCER; CANCER TISSUE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHATIC METASTASIS; MIDDLE AGED; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84861151214     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Yonemura Y., Endou Y., Tabachi K., Kawamura T., Yun H.Y., Kameya T. et al.: "Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40". Hum. Pathol., 2006, 37, 1193.
2. Schoppmann S.F., Fenzl A., Nagy K., Unger S., Bayer G., Geleff S. et al.: "VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival". Surgery, 2006, 139, 839.
3. Altieri D.C.: "Survivin, cancernetworks and pathway-directed drug discovery". Nat. Rev. Cancer, 2008, 8, 61.
4. World Health Organization. The World Health Organization histological typing of breast tumors-second edition. Am. J. Clin. Pathol., 1982, 78, 806.
5. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A.: "AJCC Cancer Staging Manual". 7th edition, New York, Springer, 2010, 347.
6. Chau N.M., Ashcroft M.: "Akt2: a role in breast cancer metastasis". Breast Cancer Res., 2004, 6, 55.
7. Jussila L., Alitalo K.: "Vascular growth factors and lymphangiogenesis". Physiol. Rev., 2002, 82, 673.
8. Farnsworth R.H., Achen M.G., Stacker S.A.: "Lymphatic endothelium: an important surface for malignant cells". Pulm. Pharmacol. Ther., 2006, 19, 51.
9. Mäkinen T., Veikkola T., Mustjoki S., Karpanen T., Catimel B., Nice E.C. et al.: "Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3". EMBO J., 2001, 20, 4762.
10. Gao P., Zhou C.Y., Zhang Q.H., Su Z.X., Zhang T.G., Xiang L. et al.: "Lymphangiogenesis in gastric carcinoma correlates with prognosis". J. Pathol., 2009, 218, 192.
11. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P. et al.: "Induction of tumor lymphangiogenes is by VEGF-C promotes breast cancer metastasis". Nat. Med., 2001, 7, 192.
12. Nakamura Y., Yasuoka H., Tsujimoto M., Imabun S., Nakahara M., Nakao K. et al.: "Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res. Treat. 2005, 91, 125.
13. Johnson M.E., Howerth E.W.: "Survivin: A bifunctional Inhibitor of apoptosis protein". Vet. Patho., 2004, 41, 599.
14. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., Tanigawa N.: "Expression of survivin and its relationship to loss of apoptosis in breast carcinomas". Clin. Cancer Res., 2006, 6, 127.
15. Tan G., Cioc A.M., Perez-Montiel D., Ellison E.C., Frankel W.L.: "Microvascular density dose not correlate with histopathology and outcome in neuroendocrine tumors of the pancereas". Appl. Immunohistochem. Mol. Morphol., 2004, 12, 31.